Retraction notice to "Stress-driven discovery in the natural products: A gateway towards new drugs" [Biomedicine & Pharmacotherapy 109 (2019) 459-467] - 25/03/26
Doi : 10.1016/j.biopha.2026.119149
Syed Shams ul Hassan a, Hui-zi Jin a, ⁎, Tareq Abu-Izneid b, Abdur Rauf c, ⁎, Muhammad Ishaq a, Hafiz Ansar Rasul Suleria d, e, f
a School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China
b Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University of Science and Technology, Al Ain Campus, UAE
c Department of Chemistry, University of Swabi, Anbar Swabi, 25120, KPK, Pakistan
d UQ Diamantina Institute, Translational Research Institute, Faculty of Medicine, The University of Queensland, 37 Kent Street Woolloongabba, Brisbane, QLD 4102, Australia
e Centre for Chemistry and Biotechnology, School of Life and Environmental Sciences, Deakin University, Pigdons Road, Waurn Ponds, Victoria 3216, Australia
f School of Agriculture and Food, The University of Melbourne, Parkville, VIC 3010, Australia
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119149- avril 2026 Retour au numéro
Article précédent
- Retraction notice to "ATP ion channel P2X purinergic receptors in inflammation response" [Biomedicine & Pharmacotherapy 158 (2023) 114205]
- Ji-peng Liu, Si-cheng Liu, Shi-qi Hu, Jia-feng Lu, Chang-lei Wu, Dong-xia Hu, Wen-jun Zhang
- Retraction notice to "Nanoparticles as an effective drug delivery system in COVID-19" [Biomedicine & Pharmacotherapy 143 (2021) 112162]
- Neehasri Kumar Chowdhury, Reshma Choudhury, Gaurav Ambadas Sonawane, Shankar Mavinamar, Xiaoming Lyu, Ramendra Pati Pandey, Chung-Ming Chang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?